Risk prediction in chronic kidney disease: Pitfalls and caveats

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 6, 2012, Pages 612-618

  Rigatto, Claudio ^a   Sood, Manish M ^b   Tangri, Navdeep ^a  

^a Seven Oaks General Hospital   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

all cause mortality; chronic kidney disease; kidney failure; risk prediction

Indexed keywords

CREATININE;

ACCURACY; ALBUMINURIA; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DIABETIC NEPHROPATHY; DISEASE COURSE; EXTERNAL VALIDITY; FACE VALIDITY; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INTERNAL VALIDITY; KIDNEY FAILURE; MICROALBUMINURIA; MORTALITY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROGNOSIS; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84868213179     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328359072f     Document Type: Review

References (26)

1. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
2. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72:247-259.
3. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387.
4. Steyerberg E. Clinical prediction models: a practical approach to development, validation and updating. New York: Springer; 2009.
5. Leslie WD, Morin S, Lix LM. A before-and-after study of fracture risk reporting and osteoporosis treatment initiation. Ann Intern Med 2010; 153:580-586.
6. Dorresteijn JA, Visseren FL, Ridker PM, et al. Estimating treatment effects for individual patients based on the results of randomised clinical trials. BMJ 2011; 343:d5888.
7. Batsis JA, Lopez-Jimenez F. Cardiovascular risk assessment: from individual risk prediction to estimation of global risk and change in risk in the population. BMC Med 8:29.
8. Levey AS, Tangri N, Stevens LA. Classification of chronic kidney disease: a step forward. Ann Intern Med 2011; 154:65-67.
9. Geddes CC, Fox JG, Allison ME, et al. An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists. Nephrol Dial Transplant 1998; 13:67-71.
10. Tangri N, Ansell D, Naimark D. Predicting technique survival in peritoneal dialysis patients: comparing artificial neural networks and logistic regression. Nephrol Dial Transplant 2008; 23:2972-2981.
11. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928-935.
12. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21:128-138.
13. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172.
14. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30:11-21.
15. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 16:965-980.
16. Bates DW, Ebell M, Gotlieb E, et al. A proposal for electronic medical records in U.S. primary care. J Am Med Inform Assoc 2003; 10:1-10.
17. Hillestad R, Bigelow J, Bower A, et al. Can electronic medical record systems transform healthcare? Potential health benefits, savings, and costs. Health Aff (Millwood) 2005; 24:1103-1117.
18. Maviglia SM, Teich JM, Fiskio J, Bates DW. Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines. J Gen Intern Med 2001; 16:531-537.
19. Muller-Riemenschneider F, Holmberg C, Rieckmann N, et al. Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study. Arch Intern Med 170:719-724.
20. Johnson ES, Thorp ML, Yang X, et al. Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis 2007; 50:559-565.
21. Johnson ES, Thorp ML, Platt RW, Smith DH. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis 2008; 52:653-660.
22. Keane WF, Zhang Z, Lyle PA, et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol 2006; 1:761-767.
23. Goto M, Wakai K, Kawamura T, et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 2009; 24:3068-3074.
24. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305:1553-1559.
25. Weiner DE, Tighiouart H, Elsayed EF, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007; 50:217-224.
26. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293:1737-1745.